Furthermore, several groups have reported that pancreatic cancers with the loss of E-cadherin had a poorer prognosis; therefore, E-cadherin expression has emerged as an independent prognostic factor [8, 26]. The gene discussed is CDH1; the disease is familial pancreatic carcinoma.